x 

0 Activities
0 Activities
    • No Saved Activities

Education

  2. Home
  3. Education
Page 21 of 21
Results 601 - 626 of 626
biosims-full7
Biosimilars: As Safe and Effective as the Reference Product?
biosims-green
Drift and the Manufacturing of Biologics: What is it and Does it Matter?
No image set
Radiologic Features of IPF
No image set
Gwen: A lawyer with a history of MI has a dry cough and trouble with stairs
No image set
Elizabeth: Loves the outdoors but bothered by persistent cough and GERD
No image set
Toni: Too tired to continue teaching and experiencing painful heartburn
No image set
Individualizing Patient Education in Treatment Choice: Practical Strategies
lgmw-05
A 30 y/o Female w/2-year History of Shoulder Weakness and Elevated AST and ALT
lgmw-04
32 y/o Male w/Progressive Weakness, Dilated Cardiomyopathy & Respiratory...
lgmw-03
A 60 y/o Male w/4-year History Of Shoulder Weakness
biosims-full8
Biosimilars in Clinical Practice: Interchangeability and Extrapolation
No image set
Individualizing Patient Education in Treatment Choice: Practical Strategies
No image set
Addressing Common Barriers to Adherence
9529-00028
Approach to Genetic Testing in Myopathies
9529-00014
Molecular Diagnosis of Limb-Girdle Muscle Weakness
No image set
Discovering New Drugs for IPF
No image set
Biomarkers for IPF
No image set
New Trends in IPF
No image set
New Trends in IPF
No image set
Treatment Dilemmas Case Study: Harrison
No image set
A New Era in IPF: Trials and Treatments
No image set
Highlights from ATS 2014: Discussions on Clinical Trial Data
No image set
Highlights from ATS 2014: Update on Predicting Clinical Progression
No image set
Highlights from ATS 2014: Top Line Clinical Trial Results - ASCEND, INPULSIS, and PANTHER
No image set
Exciting IPF Developments from 2015 ERS
No image set
Exciting Developments from 2015 CHEST
Page 21 of 21

Search